Conclusively, this is the first study on EMT-like CTCs in ovarian cancer, reporting that platinum-based chemotherapy provokes a shift of molecular phenotypes towards PI3Kα and Twist expressing CTCs, which may reflect clonal tumor evolution. The gene discussed is TWIST1; the disease is ovarian carcinoma.